Reports for APOTEX INC

Company Name
APOTEX INC

Shortage reports

Actual shortage:

220 (7%)

Anticipated shortage:

0 (0%)

Avoided shortage:

10 (0%)

Resolved:

3124 (93%)

3354

Discontinuation Reports

To be discontinued:

25 (7%)

Discontinued:

342 (93%)

Reversed:

0 (0%)

367

146 (4%)

70 (29%)

Shortage reports
Brand name Strength Dosage Status Date Created Date Updated Reports
TIZANIDINE 4MG TABLET Resolved 2019-04-29 2019-05-27 82759
TRAMADOL 50MG TABLET Resolved 2019-03-06 2019-03-21 77928
TRAMADOL 50MG TABLET Resolved 2018-01-09 2018-02-01 35364
TRI-CIRA 21 0.035MG 0.25MG 0.035MG 0.215MG 0.035MG 0.18MG TABLET Resolved 2022-12-02 2023-03-16 176945
TRI-CIRA 21 0.035MG 0.25MG 0.035MG 0.215MG 0.035MG 0.18MG TABLET Resolved 2024-01-05 2024-02-02 215236
TRI-CIRA 21 0.035MG 0.25MG 0.035MG 0.215MG 0.035MG 0.18MG TABLET Resolved 2023-04-06 2023-08-12 188979
TRI-CIRA 28 0.035MG 0.25MG 0.035MG 0.215MG 0.035MG 0.18MG TABLET Resolved 2023-03-23 2023-08-12 187715
TRI-CIRA LO 21 0.025MG 0.25MG 0.025MG 0.215MG 0.025MG 0.18MG TABLET Resolved 2022-02-22 2022-03-07 155371
TRI-CIRA LO 21 0.025MG 0.25MG 0.025MG 0.215MG 0.025MG 0.18MG TABLET Resolved 2022-10-28 2023-04-14 172942
TRICIRA LO 0.025MG 0.025MG 0.025MG 0.180MG 0.215MG 0.250MG TABLET Resolved 2019-11-13 2019-11-18 98575
TRICIRA LO 0.025MG 0.025MG 0.025MG 0.180MG 0.215MG 0.250MG TABLET Resolved 2018-01-18 2018-02-23 36429
TRICIRA LO 0.025MG 0.025MG 0.025MG 0.180MG 0.215MG 0.250MG TABLET Resolved 2018-12-27 2019-01-23 70526
TRICIRA LO 0.025MG 0.025MG 0.025MG 0.180MG 0.215MG 0.250MG TABLET Resolved 2019-03-05 2019-05-21 77902
TRICIRA LO 0.025MG 0.025MG 0.025MG 0.180MG 0.215MG 0.250MG TABLET Resolved 2019-03-13 2019-05-21 78558
TRICIRA LO 0.025MG 0.025MG 0.025MG 0.180MG 0.215MG 0.250MG TABLET Resolved 2019-04-10 2019-08-26 80931
TRICIRA LO 0.025MG 0.025MG 0.025MG 0.180MG 0.215MG 0.250MG TABLET Resolved 2019-08-07 2019-08-26 91109
TRIMEBUTINE 100MG TABLET Resolved 2021-11-24 2021-12-24 149793
TRIMEBUTINE 100MG TABLET Resolved 2023-02-03 2023-04-17 183589
TRIMEBUTINE 100MG TABLET Resolved 2023-07-14 2023-08-14 198716
ZAMINE 21 0.03MG 3MG TABLET Resolved 2023-11-17 2023-12-22 210668

Showing 3321 to 3340 of 3354

Discontinuation reports
Brand name Strength Dosage Status Date Created Date Updated Reports
APO-BISACODYL 5MG TABLET (DELAYED-RELEASE) Discontinued 2018-09-07 2018-09-15 60288
APO-BOSENTAN 62.5MG TABLET Discontinued 2019-01-04 2019-01-04 71339
APO-BOSENTAN 125.0MG TABLET Discontinued 2019-01-04 2019-01-04 71342
APO-BOSENTAN 125.0MG TABLET Discontinued 2018-09-07 2018-10-31 60291
APO-BRIMONIDINE 0.2% SOLUTION Discontinued 2018-09-07 2018-12-28 60301
APO-BRIMONIDINE 0.2% SOLUTION Discontinued 2020-11-16 2020-11-16 128438
APO-BRIMONIDINE 0.2% SOLUTION To be discontinued 2018-09-07 2018-09-07 60294
APO-BROMAZEPAM - TAB 1.5MG 1.5MG TABLET To be discontinued 2018-09-07 2018-09-07 60304
APO-BROMAZEPAM - TAB 3MG 3MG TABLET Discontinued 2018-09-07 2019-06-12 60307
APO-BROMAZEPAM - TAB 6MG 6MG TABLET Discontinued 2018-09-07 2018-10-19 60310
APO-CANDESARTAN 16MG TABLET Discontinued 2018-09-07 2018-09-15 60313
APO-CANDESARTAN 16MG TABLET Discontinued 2018-09-07 2018-09-15 60316
APO-CANDESARTAN 8MG TABLET Discontinued 2018-09-07 2018-09-15 60325
APO-CANDESARTAN 8MG TABLET Discontinued 2018-09-07 2018-09-15 60322
APO-CANDESARTAN 4MG TABLET Discontinued 2018-09-07 2018-09-15 60319
APO-CANDESARTAN 32MG TABLET Discontinued 2018-09-07 2018-09-15 60328
APO-CANDESARTAN/HCTZ 12.5MG 16.0MG TABLET Discontinued 2018-09-07 2018-09-15 60331
APO-CANDESARTAN/HCTZ 25MG 32MG TABLET Discontinued 2018-02-26 2018-05-03 41011
APO-CANDESARTAN/HCTZ 12.5MG 32MG TABLET Discontinued 2018-02-26 2018-02-26 41020
APO-CANDESARTAN/HCTZ 12.5MG 16.0MG TABLET Discontinued 2018-02-26 2018-02-26 41047

Showing 81 to 100 of 367